In the current study, serum fasting glucagon concentration was significantly higher in hypothyroid patients with and without NAFLD than in healthy controls; glucagon was also significantly higher in the hypothyroid patients with NAFLD than in those without NAFLD. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.